Abstract:Abstract STUDY QUESTION Can whole-exome sequencing (WES) reveal pathogenic mutations in two consanguineous Pakistani families with infertile patients? SUMMARY ANSWER A homozygous spermatogenesis associated 22 (SPATA22) frameshift mutation (c.203del), which disrupts the interaction with meiosis specific with OB-fold (MEIOB), and a MEIOB splicing mutation (c.683-1G>A) that led to loss of MEIOB protein cause familial infertility. WHAT IS KNOWN ALREADY MEIOB and SPATA22, direct binding partners and functional collaborators, form a meiosis-specific heterodimer that regulates meiotic recombination. The protein stability and the axial localization of MEIOB and SPATA22 depend on each other. Meiob and Spata22 knockout mice have the same phenotypes: mutant spermatocytes can initiate meiotic recombination but are unable to complete DSB repair, leading to crossover formation failure, meiotic prophase arrest, and sterility. STUDY DESIGN, SIZE, DURATION We performed WES for the patients and controls in two consanguineous Pakistani families to screen for mutations. The pathogenicity of the identified mutations was assessed by in vitro assay and mutant mouse model. PARTICIPANTS/MATERIALS, SETTING, METHODS Two consanguineous Pakistani families with four patients (three men and one woman) suffering from primary infertility were recruited. SPATA22 and MEIOB mutations were screened from the WES data, followed by functional verification in cultured cells and mice. MAIN RESULTS AND THE ROLE OF CHANCE A homozygous SPATA22 frameshift mutation (c.203del) was identified in a patient with non-obstructive azoospermia (NOA) from a consanguineous Pakistani family and a homozygous MEIOB splicing mutation (c.683-1G>A) was identified in two patients with NOA and one infertile woman from another consanguineous Pakistani family. The SPATA22 mutation destroyed the interaction with MEIOB. The MEIOB splicing mutation induced Exon 9 skipping, which causes a 32aa deletion in the oligonucleotide-binding domain without affecting the interaction between MEIOB and SPATA22. Furthermore, analyses of the Meiob mutant mice modelling the patients’ mutation revealed that the MEIOB splicing mutation leads to loss of MEIOB proteins, abolished SPATA22 recruitment on chromosome axes, and meiotic arrest due to meiotic recombination failure. Thus, our study suggests that SPATA22 and MEIOB may both be causative genes for human infertility. LIMITATIONS, REASONS FOR CAUTION As SPATA22 and MEIOB are interdependent and essential for meiotic recombination, screening for mutations of SPATA22 and MEIOB in both infertile men and women in larger cohorts is important to further reveal the role of the SPATA22 and MEIOB heterodimer in human fertility. WIDER IMPLICATIONS OF THE FINDINGS These findings provide direct clinical and functional evidence that mutations in SPATA22 and MEIOB can cause meiotic recombination failure, supporting a role for these mutations in human infertility and their potential use as targets for genetic diagnosis of human infertility. STUDY FUNDING/COMPETING INTEREST(S) This work was supported by the National Key Research and Developmental Program of China (2018YFC1003900, 2018YFC1003700, and 2019YFA0802600), the National Natural Science Foundation of China (31890780, 31630050, 32061143006, 82071709, and 31871514), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB19000000). The authors declare no conflicts of interest. TRIAL REGISTRATION NUMBER N/A.

Novel WEE2 Homozygous Mutations C.1346c>t and C.949a>t Identified in Primary Infertile Women Due to Unexplained Fertilization Failure.

Novel Mutations in WEE2: Expanding the Spectrum of Mutations Responsible for Human Fertilization Failure

A Novel Homozygous Missense Mutation of WEE2 Causes Female Infertility Characterized by Fertilization Failure

Homozygous Mutations in REC114 Cause Female Infertility Characterised by Multiple Pronuclei Formation and Early Embryonic Arrest

Homozygous Mutations in WEE2 Cause Fertilization Failure and Female Infertility.

Homozygous Variants in CDC23 Cause Female Infertility Characterized by Oocyte Maturation Defects.

Novel Mutations in ZP1, ZP2, and ZP3 Cause Female Infertility Due to Abnormal Zona Pellucida Formation.

Identification novel mutations in TUBB8 in female infertility and a novel phenotype of large polar body in oocytes with TUBB8 mutations

The Identification of Novel Mutations in PLCZ1 Responsible for Human Fertilization Failure and a Therapeutic Intervention by Artificial Oocyte Activation.

Novel Mutations in the PLCZ1 Gene Associated with Human Low or Failed Fertilization

Novel Mutations in ZP1: Expanding the Mutational Spectrum Associated with Empty Follicle Syndrome in Infertile Women.

Identification novel mutations and phenotypic spectrum expanding in PATL2 in infertile women with IVF/ICSI failure

Identification of Novel Mutations in CDC20: Expanding the Mutational Spectrum for Female Infertility

Novel ZP1 Pathogenic Variants Identified in an Infertile Patient and a Successful Live Birth Following ICSI Treatment

A Novel Homozygous Variant in ZFP36L2 Cause Female Infertility Due to Oocyte Maturation Defect

Identification of DNAH6 Mutations in Infertile Men with Multiple Morphological Abnormalities of the Sperm Flagella

A Novel Homozygous Missense ZP1 Variant Result in Human Female Empty Follicle Syndrome

Mutational Analysis of IZUMO1R in Women with Fertilization Failure and Polyspermy after in Vitro Fertilization

A Novel Homozygous Mutation in WDR19 Induces Disorganization of Microtubules in Sperm Flagella and Nonsyndromic Asthenoteratospermia

Whole-exome sequencing of consanguineous families with infertile men and women identifies homologous mutations in SPATA22 and MEIOB

Biallelic Mutations in WDR12 Are Associated with Male Infertility with Tapered-Head Sperm.